Frequency of anticancer drug use at the end of life: a scoping review.
Saved in:
| Title: | Frequency of anticancer drug use at the end of life: a scoping review. |
|---|---|
| Authors: | Szigethy E; PhD Programme in Biomedical Research Methodology and Public Health, Universitat Autònoma de Barcelona, Barcelona, Spain. szigethy@epidy.com.; Epidy Kft, Debrecen, Hungary. szigethy@epidy.com., Dorantes R; Centre Assistencial Dr. Emili Mira, Parc de Salut Mar, Santa Coloma de Gramenet, Barcelona, Spain., Sugrañes M; School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Madera M; Research Department, Faculty of Dentistry, University of Cartagena, Cartagena, Colombia., Sola I; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain., Urrútia G; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain., Bonfill X; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain. |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jan; Vol. 26 (1), pp. 178-189. Date of Electronic Publication: 2023 Jun 08. |
| Publication Type: | Journal Article; Scoping Review |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37286888 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Frequency of anticancer drug use at the end of life: a scoping review. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Szigethy+E%22">Szigethy E</searchLink>; PhD Programme in Biomedical Research Methodology and Public Health, Universitat Autònoma de Barcelona, Barcelona, Spain. szigethy@epidy.com.; Epidy Kft, Debrecen, Hungary. szigethy@epidy.com.<br /><searchLink fieldCode="AU" term="%22Dorantes+R%22">Dorantes R</searchLink>; Centre Assistencial Dr. Emili Mira, Parc de Salut Mar, Santa Coloma de Gramenet, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sugrañes+M%22">Sugrañes M</searchLink>; School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Madera+M%22">Madera M</searchLink>; Research Department, Faculty of Dentistry, University of Cartagena, Cartagena, Colombia.<br /><searchLink fieldCode="AU" term="%22Sola+I%22">Sola I</searchLink>; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Urrútia+G%22">Urrútia G</searchLink>; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bonfill+X%22">Bonfill X</searchLink>; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101247119%22">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</searchLink> [Clin Transl Oncol] 2024 Jan; Vol. 26 (1), pp. 178-189. <i>Date of Electronic Publication: </i>2023 Jun 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Scoping Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Italia%22">Springer Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>101247119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1699-3055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221699048X%22">1699048X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37286888 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12094-023-03234-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 178 Titles: – TitleFull: Frequency of anticancer drug use at the end of life: a scoping review. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Szigethy E – PersonEntity: Name: NameFull: Dorantes R – PersonEntity: Name: NameFull: Sugrañes M – PersonEntity: Name: NameFull: Madera M – PersonEntity: Name: NameFull: Sola I – PersonEntity: Name: NameFull: Urrútia G – PersonEntity: Name: NameFull: Bonfill X IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2024 Jan Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1699-3055 Numbering: – Type: volume Value: 26 – Type: issue Value: 1 Titles: – TitleFull: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Type: main |
| ResultId | 1 |